Back to Newsroom

Corbus Pharmaceuticals Announces Inclusion in Russell 3000(R) Index

NORWOOD, MA — (Marketwired) — 06/26/17 — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP)(“Corbus” or the “Company”), a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today that it was added to the Russell 3000® Index at the conclusion of the Russell indexes annual reconstitution on June 23, 2017.